Stocks · Healthcare · Drug Manufacturers - Specialty & Generic
Cumberland Pharmaceuticals Inc. CPIX
$7.39 -1.60% Close, Oct 2, 2026 · NASDAQ · Market cap $110.7M
Strong trend
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -30.8% from -7.1% a year earlier.
- Over the past year the stock returned +136.9%, ahead of the S&P 500 by 121.8 percentage points.
- Revenue over the last four quarters was $31.3M, down 25.7% from a year earlier, slowing from 2.1% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 15%
- FCF growth (TTM, YoY)Bottom 12%
- Revenue growth, 3-year CAGRBottom 28%
- Revenue growth accelerationBottom 10%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 38%
- Gross marginTop 27%
- Operating marginBottom 40%
- Accruals (lower is better)Top 17%
- Interest coverBottom 21%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 46%
- Free-cash-flow yieldTop 39%
- EBITDA / enterprise valueBottom 49%
- Sales / enterprise valueTop 44%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 15%
- 6-month returnTop 5%
- 1-year return vs S&P 500Top 9%
- Distance from 52-week highTop 33%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 21%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 25%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 14%
- Maximum drawdown, 3 yearsBottom 48%
- Beta vs S&P 500 (lower is better)Top 4%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 2.1% | -25.7% | ↓ |
| Gross margin | 84.0% | 83.4% | ↓ |
| Operating margin | -7.1% | -30.8% | ↓ |
| FCF margin | 16.8% | -3.6% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -25.7% | 2.1% | ↓ | Bottom 15% |
| Gross margin | 83.4% | 84.0% | ↓ | Top 27% |
| Operating margin | -30.8% | -7.1% | ↓ | Bottom 40% |
| Net margin | -33.9% | -7.0% | ↓ | — |
| Free-cash-flow margin | -3.6% | 16.8% | ↓ | — |
| Return on invested capital | -34.1% | — | Bottom 38% | |
| Revenue growth, 3-year CAGR | 2.0% | — | Bottom 28% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -18.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +55.8 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -31.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -4.69%
- Shareholder yield
- -4.69%
- Share count change, 1 year
- +0.1%
- Share count change, 3-year CAGR
- +1.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +23.1%
- Average 2-day reaction, last 8
- +1.3%
- Positive 20 days after report
- 2 of 8
Analysts
- Analysts with a rating
- 5
- Share rating Buy or Strong Buy
- 60%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | -53.8% | +8.2% | +8.5% | -6.8% | — |
| May 5, 2026 | +0.0% | +0.4% | +0.9% | +27.4% | +48.6% |
| Mar 3, 2026 | +92.3% | -5.4% | -29.5% | -35.5% | +21.1% |
| Nov 4, 2025 | +53.8% | -3.6% | -28.3% | -21.7% | +35.9% |
| Aug 5, 2025 | — | -5.5% | -29.2% | -8.0% | -17.7% |
| May 6, 2025 | +1700.0% | -1.3% | +17.9% | +29.3% | -22.8% |
| Mar 4, 2025 | +81.8% | +17.7% | -2.9% | -17.7% | +13.6% |
| Nov 7, 2024 | +84.6% | +0.0% | -1.7% | -1.7% | +323.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | -$0.20 | -$0.13 | -53.8% | $166,458 |
| May 5, 2026 | -$0.13 | -$0.13 | +0.0% | $9.1M |
| Mar 3, 2026 | -$0.01 | -$0.13 | +92.3% | $13.7M |
| Nov 4, 2025 | -$0.06 | -$0.13 | +53.8% | $8.3M |
| Aug 5, 2025 | $0.02 | — | — | $10.8M |
| May 6, 2025 | $0.16 | -$0.01 | +1700.0% | $11.7M |
| Mar 4, 2025 | -$0.02 | -$0.11 | +81.8% | $10.4M |
| Nov 7, 2024 | -$0.02 | -$0.13 | +84.6% | $9.1M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 3.57× | — | — | Top 44% |
| Free-cash-flow yield | -1.00% | — | — | Top 39% |
| Earnings yield | -9.67% | — | — | Bottom 46% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 113
- 50-day average slope (20 days)
- +2.7%
- 200-day average slope (20 days)
- +10.5%
- Distance from 50-day average
- -0.1%
- Distance from 200-day average
- +39.9%
- RSI (14)
- 49.5
- Relative volume
- 0.58×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 86.8%
- Volatility vs own 5-year history
- 69th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.10
- Correlation with S&P 500
- 0.01
- Current drawdown from 1-year high
- -17.6%
- Maximum drawdown, 3 years
- -71.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 6, 2021 | Nov 22, 2024 | -84.7% | 745 days | 399 days (Jul 1, 2026) |
| Feb 16, 2021 | Nov 29, 2021 | -38.6% | 199 days | 1 days (Nov 30, 2021) |
| Aug 26, 2026 | Sep 9, 2026 | -29.9% | 9 days | Not yet recovered |
| Nov 30, 2021 | Dec 1, 2021 | -18.5% | 1 days | 3 days (Dec 6, 2021) |
| Jul 1, 2026 | Jul 10, 2026 | -16.8% | 6 days | 3 days (Jul 15, 2026) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $110.7M
- EPS, diluted (TTM)
- -$0.71
- Revenue (TTM)
- $31.3M
- Dividend yield
- 20.30%
- 52-week range
- $1.85 – $9.28
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $36.0M | $42.0M | $39.6M | $37.9M | $44.5M |
| Gross profit | $27.2M | $32.9M | $33.5M | $31.3M | $37.9M |
| Operating income | -$7.7M | -$5.7M | -$9.6M | -$6.4M | -$2.8M |
| Net income | -$3.5M | -$5.6M | -$6.3M | -$6.5M | -$2.8M |
| EPS (diluted) | -$0.24 | -$0.38 | -$0.44 | -$0.46 | -$0.19 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.1M | $10.4M | $11.7M | $10.8M | $8.3M | $13.7M | $9.1M | $166,458 |
| Net income | -$1.5M | -$1.9M | $1.3M | -$740,740 | -$1.9M | -$1.4M | -$3.1M | -$4.1M |
| EPS (diluted) | -$0.11 | -$0.14 | $0.08 | -$0.05 | -$0.13 | -$0.09 | -$0.22 | -$0.27 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $6.3M | $8.5M | $6.1M | -$612,186 | $4.9M |
| Capital expenditure | -$354,462 | -$2.1M | -$453,051 | -$179,714 | -$97,902 |
| Free cash flow | $6.0M | $6.4M | $5.6M | -$791,900 | $4.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$1.4M | -$1.1M | -$740,533 | -$579,049 | $5.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $3.9M
- Total assets
- $62.9M
- Total liabilities
- $45.8M
- Total debt
- $4.7M
- Net debt
- $851,782
- Shareholders’ equity
- $17.4M
As of Jun 30, 2026 (filed Aug 7, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 3, 2026 | $1.50 | — |
Short interest
- Shares sold short
- 252,451
- Days to cover
- 8.07
- Change vs previous report
- -8.1%
FINRA short interest, settlement date Sep 15, 2026.